Suppr超能文献

锁骨上区域器官在乳腺癌患者内乳淋巴结(IMN)覆盖时的剂量:容积调强弧形治疗(VMAT)与 3D 和 VMAT 的比较。

Dose to organs in the supraclavicular region when covering the Internal Mammary Nodes (IMNs) in breast cancer patients: A comparison of Volumetric Modulated Arc Therapy (VMAT) versus 3D and VMAT.

机构信息

Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.

出版信息

PLoS One. 2018 Oct 19;13(10):e0205770. doi: 10.1371/journal.pone.0205770. eCollection 2018.

Abstract

During breast/chest wall and regional nodal irradiation (RNI), standard 3D conformal techniques can fail to meet the dosimetric constraints for the heart and ipsilateral lung. VMAT can improve the dosimetric sparing of the heart and lungs. However the unnecessary increase in dose to the organs in the supraclavicular region as a result of using VMAT can be avoided. In this work we investigate potential dosimetric advantages of combining 3D with VMAT to improve sparing of these organs. Ten breast cancer patients requiring radiation therapy to the breast/chest wall and RNI including the IMNs, and who did not have a viable 3D conformal plan were chosen for the study. Each patient was planned with VMAT and with a combination of 3D for the supraclavicular region and VMAT for the breast/chest wall followed by a dosimetric comparison. Prescription dose was 50.4 Gy in 28 fractions. For similar coverage to the PTV and IMNs, doses to the esophagus and cord were reduced by 17.8 Gy and 15.5 Gy while mean dose to the thyroid and larynx were also reduced by 16.5 Gy and 11.7 Gy respectively. Maximum brachial plexus dose was the same in both techniques. The ipsilateral lung V20Gy increased by 3.1% but was still < 30%. No significant differences were noted in doses to the heart, total lung and contralateral breast. However V5Gy to the contralateral lung was reduced by 8.5% with the combined plan. Using 3D conformal planning for the supraclavicular region and VMAT over the breast/chest wall improves sparing of the esophagus, cord, thyroid and larynx while reducing low dose exposure to the contralateral lung and does not compromise doses to the heart, ipsilateral lung and total lung.

摘要

在乳腺/胸壁和区域淋巴结照射(RNI)期间,标准的 3D 适形技术可能无法满足心脏和同侧肺的剂量学限制。VMAT 可以改善心脏和肺的剂量学保护。然而,由于使用 VMAT,锁骨上区域的器官会不必要地增加剂量,这可以避免。在这项工作中,我们研究了将 3D 与 VMAT 结合以改善这些器官的保护的潜在剂量优势。选择了 10 名需要进行乳腺/胸壁放射治疗和 RNI 治疗(包括 IMN)的乳腺癌患者,并且他们没有可行的 3D 适形计划。对每位患者进行了 VMAT 计划和 3D 联合计划,用于锁骨上区域的 VMAT 以及乳腺/胸壁的 VMAT,然后进行剂量比较。处方剂量为 50.4 Gy,分 28 次。对于与 PTV 和 IMN 相似的覆盖范围,食管和脊髓的剂量分别减少了 17.8 Gy 和 15.5 Gy,而甲状腺和喉的平均剂量也分别减少了 16.5 Gy 和 11.7 Gy。两种技术的臂丛神经最大剂量相同。同侧肺 V20Gy 增加了 3.1%,但仍<30%。对心脏、总肺和对侧乳房的剂量没有显著差异。然而,与联合计划相比,对侧肺的 V5Gy 减少了 8.5%。对于锁骨上区域使用 3D 适形计划,对于乳腺/胸壁使用 VMAT,可以改善食管、脊髓、甲状腺和喉的保护,同时减少对侧肺的低剂量暴露,并且不会影响心脏、同侧肺和总肺的剂量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fbf/6195271/e27719ff7d84/pone.0205770.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验